TrialEBioMedicine2019

Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial).

Emma E Morrison et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.